Overview A Phase 4 Study Investigating the Efficacy of Retaine™ in Managing Signs and Symptoms Associated With Dry Eye Syndrome Status: Completed Trial end date: 2014-05-01 Target enrollment: Participant gender: Summary This study will evaluate the efficacy of Retaine™ ophthalmic emulsion in treating the signs and symptoms of dry eye syndrome. Phase: Phase 4 Details Lead Sponsor: Ocusoft, Inc.Collaborator: ORA, Inc.Treatments: Carboxymethylcellulose Sodium